Drug intelligence / Profile preview

methdilazine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intramuscular
01

Overview

Methdilazine is a first-generation phenothiazine antihistamine with anticholinergic properties. It acts as a histamine H1 receptor antagonist, competing with histamine for binding at H1-receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. This action provides temporary relief from symptoms such as sneezing, watery and itchy eyes, and runny nose due to hay fever and other upper respiratory allergies. Methdilazine is also used to relieve pruritus in various dermatoses and has moderate sedative effects due to its antimuscarinic activity[1][2][5][6].

Brand names
TacarylTacazylAnerganAntinausHistantilPanectylPentazinePhenazinePhencenPhenerganPhenerzinePhenojectPro-MedPromacotPrometProrexProthazineShoganTemarilV-Gan–25
Other names
methdilazine hydrochloride
02

Targets

HRH1 (Histamine H1 Receptor)mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on methdilazine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methdilazine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call